ACCORD HLTHCARE FDA Approval ANDA 206058

ANDA 206058

ACCORD HLTHCARE

FDA Drug Application

Application #206058

Application Sponsors

ANDA 206058ACCORD HLTHCARE

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUSEQ 3MG BASE/3ML0IBANDRONATE SODIUMIBANDRONATE SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2016-02-05STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

ACCORD HLTHCARE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206058
            [companyName] => ACCORD HLTHCARE
            [docInserts] => ["",""]
            [products] => [{"drugName":"IBANDRONATE SODIUM","activeIngredients":"IBANDRONATE SODIUM","strength":"EQ 3MG BASE\/3ML","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/05\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"12\/12\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-12-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.